Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aemetis, Inc. Announces Business Update Conference Call

AMTX

CUPERTINO, CA--(Marketwired - Aug 12, 2014) - Aemetis, Inc. (NASDAQ: AMTX), announced that the company will host a business update conference call:

Date: Thursday, August 14, 2014

Time: 1:15 pm Pacific Time

Conference Number: +1 (605) 562-3140
Access code: 166576

Attendees may submit questions to management prior to Noon Pacific Time on August 13, 2014 to the following email address: john@liviakis.com.

After August 14th, the webcast will be archived on the Company's website (www.aemetis.com) under Investors/Conference Calls. The voice recording will also be available for 90 days by dialing +1 (605) 562-3149, access code 166576.

About Aemetis
Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company founded in 2006. Aemetis owns and operates a 60 million gallon capacity ethanol and 420,000 ton animal feed plant in California that is the first US facility approved by the EPA to produce D5 Advanced Biofuels using the sorghum/biogas/CHP pathway. Aemetis also built, owns, and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds five granted patents on its Z-microbe and related technology for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit aemetis.com.

Investor Relations:
Michael Bayes
(415) 389-4670
michaelbayes@liviakis.com

Company Contact:
Todd Waltz
(408) 213-0925
twaltz@aemetis.com

Media Contact:
Melanie Borchardt
(408) 213-0938
mborchardt@aemetis.com